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Introduction
Late life depression (LLD) is a common psychiatric disorder that is defined as a major depressive episode occurring in older adults (usually after 60 or 65 years of age). LLD is a heterogeneous mood disorder frequently associated with cognitive impairment. (Byers et al., 2010; Weisenbach et al., 2012) . Thus, it is important to distinguish between dementia and LLD clinically, but the distinction has proved to be difficult.
Indeed, several reports have suggested that LLD might be a risk factor in Alzheimer's disease (AD) (Jorm, 2001; Diniz et al., 2013) . Moreover, some forms of LLD are considered to constitute prodromal symptoms of dementia (Schweitzer et al., 2002) . Consistent with this, Ownby et al. (2006) reported that a history of depression is associated with an increased risk for developing AD.
Magnetic resonance imaging (MRI) studies have found that a history of depression and total duration of depression is correlated with hippocampal volume loss (Sheline et al., 1996; Bell-McGinty et al., 2002) . A relationship between reduced hippocampal volume and LLD specifically has also been reported, and this is also associated with poor performance on the Mini-Mental State Examination (MMSE), a test used to assess cognitive impairment (Sawyer et al., 2012 ). There appears to be a general consensus that in a subset of LLD patients, there is a reduction in the volume of brain regions that are affected early in AD, including frontal and medial temporal lobe (MTL) structures (Sexton et al., 2012) . A number of potential mechanisms underlying hippocampal atrophy in dementia have been proposed. One possible explanation is that glucocorticoid-induced neurotoxicity induces hippocampal neural loss, leading to dementia (Lupien et al., 1998) . Alternatively, cortisol-induced atrophy of the hippocampus may increase amyloid plaque deposition, which may be a risk factor, or prodromal indicator, of dementia (Byers and Yaffe, 2011) . While there are several lines of evidence that link hippocampal atrophy to AD, the cause of hippocampal atrophy in late-onset LLD and its relationship to AD has not yet been determined.
The voxel-based specific regional analysis system for AD (VSRAD), which targets the MTL, was developed as a sensitive diagnostic tool to detect early stages of AD (Hirata et al., 2005) . VSRAD enabled the evaluation of the degree of entorhinal cortex and parahippocampal volume loss by comparing a given subject's gray matter (GM) volume with that of the original healthy individual database template. The Z-score obtained from the VSRAD became an indicator of the degree of GM atrophy of the hippocampal region in the diagnosis of early AD. A Z-score 42 was defined as significant atrophy of the hippocampal region according to previous studies Matsuda, 2013) . However, a Z-score 42 is not necessarily synonymous with a diagnosis of early AD, and, conversely, a diagnosis of LLD, which does not show the same cognitive deficits as AD, may be associated with this Z-score. In addition to being used in the early diagnosis of AD, the VSRAD approach has been used to estimate regional GM atrophy in depression.
Thus, in this study, we used VSRAD to compare regional GM volume abnormalities in AD with those observed in late-onset LLD. It is thought that the degree of atrophy of MTL structures is generally related to the grade of memory impairment. However, because the cause of the hippocampal atrophy in LLD was not clear in the present cases, where the grade of degeneration of MTL structures coincided with that found in AD, we predicted that there would be neuropathologically different features between LLD and AD, even when the degree of hippocampal atrophy between the two diseases was comparable. Thus, based on previous MRI studies in AD and LLD patients, we hypothesized that AD patients may show greater GM volume abnormalities in temporal and parietal regions, in particular the posterior cingulate gyrus and precuneus, while LLD patients may show greater GM volume abnormalities in frontal and limbic regions, including the anterior cingulate cortex.
Methods

Subjects
This study was conducted with the approval of the ethics committee of Nippon Medical School Chiba Hokuso Hospital. The purpose of the study was explained to all subjects, both verbally and in written form, and their informed consent was obtained. Participants were recruited for this study from a group of 188 outpatients (54-92 years of age) who visited Nippon Medical School Chiba Hokuso Hospital complaining of memory loss, and who subsequently underwent MRI scans for VSRAD analysis between January 2011 and December 2012. The 38 patients (15 males/23 females) who were included in this study obtained a VSRAD Z-score of two or more. The subjects were divided into two groups. Of the 38 patients, 21 met (1) the DSM-IV-TR criteria for AD, and (2) the consensus criteria of the National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) for probable AD. The remaining 17 patients met DSM-IV-TR criteria for major depressive disorder (MDD) as well as satisfying the criteria in the International Classification of Diseases, 10th version (ICD-10). All MDD patients had experienced an onset of major depressive episodes at 60 years of age or older, consistent with a diagnosis of LLD. AD patients with a history of depression, and LLD patients with mild cognitive impairments (MCI; defined by Petersen et al. (2001) ) or cognitive impairment beyond this, seen clinically as 0.5 or more on the Clinical Dementia Rating (CDR) Scale and an MMSE of 23 or less, were excluded from the study. Participants were also excluded if they met criteria for another major psychiatric illness (schizophrenia, schizoaffective disorder, bipolar disorder). Patients with LDD who had received electroconvulsive therapy were excluded. Patients with a neurological illness other than dementia that could lead to cognitive impairment or that was associated with structural brain changes, and those with a history of brain injury, were also excluded from the study.
Initial assessment
General cognitive function was assessed with the Mini Mental State Examination (MMSE) (Folstein et al., 1975) and the Alzheimer's Disease Assessment Scale (ADAS) word recall subtest (Mohs et al., 1983; Honma et al., 1992) . Participants were asked for their history of depressive episodes. A history of drug therapy and age of onset were determined from a questionnaire and from family interviews. Symptoms and severity of depression were assessed using the 17-item Hamilton Depression Rating Scale (HAM-D) (Hamilton, 1960) at the initial interview.
MRI measurement
All subjects underwent T1 and T2 two-dimensional diffusion weightedechoplanar imaging in a 1.5 T MRI system (Signa Horizon HD, GE Healthcare Technologies, Milwaukee, WI, USA). For VSRAD analysis, three-dimensional sagittal sections of the brains were acquired with the following parameters: inversion time 400 ms, repetition time 11.8 ms, echo time 5.1 ms, flip angle 251, field of view 240 mm, acquisition matrix, 256 Â 256, and slice thickness 1.4 mm.
Voxel-based morphometry
VSRAD Advance (Eisai Co, Ltd, Tokyo, Japan) segmented the MRI scans into gray matter (GM), white matter (WM), and cerebrospinal fluid (CSF) images by a unified tissue-segmentation procedure after correcting for image-intensity non-uniformity. These linearly transformed and segmented images were nonlinearly transformed by DARTEL procedures and then modulated to the customized template for DARTEL followed by smoothing using an 8-mm full width at half-maximum kernel. The segmented images were compared with the mean and standard deviation of the GM or WM images of the 80 healthy controls that are included in the VSRAD software using voxel by-voxel Z-score analysis (Z-score¼ ([control-mean] À [individual value])/(control SD)). These Z-score maps were superimposed on tomographic sections of each individual brain. VSRAD registered the target volume of interest (VOI) in the medial temporal structures including the entire region of the entorhinal cortex, hippocampus, and amygdala. This was accomplished by comparing the VOI in patients with early AD with that of healthy controls. First, statistical analysis for the jackknife method comparing the image of the individual patient and the mean image of the healthy control database is used in VSRAD. Therefore, the mean image of each group was created using SPM8 (Statistical Parametric Mapping version 8, Wellcome Department of Imaging Neuroscience, London, UK). A Z-score map of GM loss is created by mean image comparison for each group and mean image of a healthy control database using VSRAD. Next, using global normalized GM data processed by VSRAD based on SPM8 plus DARTEL, the GM volume difference between the LLD group and the AD group was investigated by multivariate analysis of variance (MANCOVA), with age, education, duration of illness, and Z-score as covariates. A whole-brain between-group comparison (LLD4AD and AD 4LLD) search for significant clusters with an extent threshold of more than 15 voxels was performed under an uncorrected threshold of po 0.001. In addition, regional GM changes were evaluated using the Wake Forest University (WFU) PickAtlas tool (Maldjian, o http://www.nitrc.org/projects/wfu_pickatlas 4) (Tzourio-Mazoyer et al., 2002) . The WFU PickAtlas provides a method for generating region-of-interest (ROI) masks based on the Talairach Daemon database. A statistical threshold of p o0.001 was used.
Statistical analysis
Basic group comparisons such as a one-way analysis of variance (ANOVA) and a Chi-square test or a Fisher's exact test were used. Analyses were performed using JMP8 and SAS version 9 (SAS Institute, Inc., Cary, NC), and a p-value of less than 0.05 was considered statistically significant. Table 1 presents the demographic, clinical, and neuropsychological characteristics of participants. There were no significant differences in age, sex, education, or duration of disease or VSRAD Z-score between the LLD and the AD groups. However, AD subjects scored significantly lower in the MMSE and the ADAS word recall test relative to patients with LLD, indicating greater cognitive impairment in the AD group. LLD subjects (mean score 13.6 72.5, range 6-17) scored higher on the HAM-D scale relative to patients with AD (mean score 6.5 71.9, range 4-12), confirming a greater severity of depression in LLD patients. Of the 17 LLD patients, 13 were being treated with antidepressants. Eight patients with AD were taking acetylcholinesterase inhibitors (ACheI); the remaining 13 patients were not receiving any drug therapy for AD.
Results
Background characteristics
Z-score map of GM volume reductions in LLD and AD
The Z-score map indicates GM volume reduction obtained and compares the mean image of the healthy control group and the mean image of each clinical group using the VSRAD program (see Fig. 1 . Significant atrophy was observed in mesial temporal lobe structures, including the entorhinal cortex, hippocampus and amygdala, the orbitofrontal cortex, the anterior cingulate cortex, and the pons, in both groups. Significant atrophy of the posterior cingulate cortex (PCC), precuneus and right cerebellum was found only in the AD group (Fig. 1). 
Comparison of regional GM volume between LLD and AD patients
We compared the GM volumes in the LLD group and the AD group. An automated atlas-based VOI analysis method revealed a significant reduction in GM volume in the right and left precuneus, the right middle and inferior temporal gyrus, the uncus, and the PCC regions in the AD group compared with the LLD group. On the other hand, no specific GM volume was found to be significantly decreased in the LLD group relative to the AD group (Table 2) .
Discussion
Although several voxel-based morphometric studies have reported a correlation between AD and LLD (Modrego and Ferrández, 2004; Robert et al., 2006; Gabryelewicz et al., 2007; Palmer et al., 2007; Houde et al., 2008) , this study is the first to compare differences in brain structure volume in AD and lateonset LLD with comparable hippocampal atrophy. Here, we show using VSRAD that a number of regions were atrophied in both AD Fig. 1 . Z-score map of gray matter volume reductions in LLD and AD groups using VSRAD. (LLD, n ¼17; AD, n¼ 21) . VSRAD provides a color-scaled Z-score map ranging from 2.0 to 6.0 with overlaid orthogonal sections of an anatomically standardized brain template. (Purple circles indicate the VSRAD voxel of interest.). and LLD, including the parahippocampal gyrus, the amygdala and the anterior cingulate cortex, and that this reduction is dramatic compared with the healthy individual database included in the VSRAD software. However, unlike the AD group, the LLD group showed no evidence of atrophy in the precuneus and the PCC. Our findings suggest that changes in more posterior parts of the brain may be more likely to be observed in AD. These results indicate that while there are common sites of GM volume loss in AD and LLD, there are also important regional differences between the two diseases. GM volume changes in frontal-subcortical or limbic networks are hypothesized to play an important role in the neuropathology of LLD (Sexton et al., 2012) . Indeed, several previous studies have reported a reduction in the volume of the anterior cingulate cortex and frontal orbital cortex in LLD (Caetano et al., 2006; Taylor et al., 2007) . Furthermore, a previous study of LLD patients using VSRAD identified atrophy of the subgenual anterior cingulate cortex specifically (Niida et al., 2012) . This study reported that assessing for the presence of subgenual anterior cingulate cortex atrophy is also effective in the diagnosis of major depression with a sensitivity of 90.7%. In the present VBM study, using SPM8 plus DARTEL, we found GM atrophy in regions that were consistent with findings from previous VBM studies of LLD. Recent functional MRI studies have reported an association between the defaultmode network (DMN) and LLD (Wu et al., 2011; Alexopoulos et al., 2012) . In these studies, LLD patients exhibited decreased connectivity in the anterior regions of the DMN (the rostral anterior cingulate cortex, medial prefrontal and orbito-prefrontal cortex), and increased connectivity in the posterior regions of the DMN. Conversely, some studies have reported an association between the DMN and AD involving a decrease in regional coherence in the PCC and precuneus (He et al., 2007; Liu et al., 2008) . While a direct association between structural changes and functional changes in DMN inactivation has not been established, it is possible that the differences in the morphological changes in AD and LLD found in our study are related to these observations.
The most interesting aspect of the present study is the assessment of regional GM volume as a co-variable with MTL structural atrophy identified in the VSRAD analysis. Our findings identified a significant decrease in volume in the right middle and inferior temporal gyrus, uncus, PCC and precuneus only in the AD group. In previous studies, the PCC and the precuneus have been identified as the major sites of functional change in patients with AD (Minoshima et al., 1997; Nestor et al., 2003; Berti et al., 2010) , whereas structural neuroimaging studies noted a reduction in only the volume of MTL structures in early AD (Jack et al., 1999; Killiany et al., 2002) . Thus, there was a discrepancy between the structural changes and functional changes observed in AD. However, more recent VBM studies have reported the presence of precuneus, PCC, and hippocampal atrophy in early stage AD (Shiino et al., 2006; Karas et al., 2007) . A meta-analysis of recent structural neuroimaging studies identified PCC, precuneus and mid-temporal lobe GM atrophy as an antecedent biomarker that is predictive of the progression of amnestic mild cognitive impairment (aMCI) into AD (Whitwell et al., 2008; Gili et al., 2011) . Convit et al. (2000) reported that atrophy of the medial occipitotemporal, inferior, and middle temporal gyrus in non-demented elderly subjects predicted an eventual cognitive decline in AD. Also, a recent functional MRI study suggested that changes in the posterior areas of the DMN as well as in the medial temporal lobes seem to be central to AD (Sorg et al., 2009) . AD cases in our study were not in the early stages of the disease. A recent VBM study examined the structural changes associated with increasing CDR scores in AD patients. In this study, a significant decrease in the volume of MTL structures was associated with a worsening of cognitive impairments, but this was not the case for the PCC or the precuneus (Kim et al., 2011) . Consistent with this, our findings indicate the presence of precuneus, PCC, and middle and inferior temporal gyrus atrophy in AD, but not in LLD. Thus, the neuropathological changes that are observed in both AD and MCI differed from those found in late-onset LLD patients with hippocampal atrophy. This suggests that the hippocampal atrophy observed in late-onset LLD may reflect the presence of changes that differ from the hippocampal atrophy that occurs in the prodromal stage of AD. Furthermore, the neurodegeneration in the subregions of the anterior DMN, in particular the ACC, could be important in late-onset LLD patients, although some degeneration in this region is also observed in moderate to severe AD patients. The regions central to the cognitive deficit may differ between the AD and LLD groups. The cause of atrophy of the anterior cingulate cortex and how this is associated with hippocampal atrophy is complex in the LLD group. Indeed, Andreescu et al. (2008) suggest several factors that may contribute to the heterogeneity of volumetric brain changes in LLD, including age of onset, time since onset, degree of apathy, genetics, and antidepressant medication response. It is also necessary to address additional potentially confounding factors, such as genetics (e.g., isoforms of apolipoprotein E (ApoE)), the presence or absence of vascular disease, the duration of illness, and medication status. Thus, considering these factors, we believe that a longitudinal study is required to assess whether a LLD diagnosis is a risk factor for AD.
The current study had several limitations. This study only assessed cases that had a degree of hippocampal atrophy detectable by VSRAD. Therefore, the sample size used in the study was small. As a result the study had low statistical power, which reduced the chance of detecting a true effect. Second, for the AD group, we included cases of moderate as well as mild cases of cognitive impairment. Thus, patients in the AD group could have MMSE scores that were significantly lower than patients in the late-onset LLD group. Patients with LLD and aMCI and participants with aMCI alone were not included in the study. Notably, a metaanalysis of VBM studies examining MCI and AD identified similar distributions of neuroanatomical changes in AD and MCI (Yang et al., 2012) . Xie et al. (2012) hypothesized that LLD with aMCI, but not LLD alone, would be associated with widespread GM volume loss in regions commonly implicated in mild AD. Future studies should include comparison of cases with and without aMCI. A longitudinal observational study of the present LLD cases is also necessary. Furthermore, examination of psychological test batteries, such as those for executive function, will be needed to determine what kind of cognitive difficulties are associated with the structural abnormalities, common to both the AD and LLD groups, observed in the frontal part of the DMN containing the ACC.
Conclusion
Our study revealed structural changes in the anterior DMN in both the AD and LLD groups, whereas structural changes in the posterior DMN were only observed in the AD group.
These findings were consistent with our results obtained using atlas-based VBM. Significantly decreased GM volume in the precuneus and PCC regions was seen in the AD group relative to the LLD group. The late-onset LLD group exhibited morphological changes different from those observed in AD, supporting the results from previous VBM studies. Importantly, because LLD is a collection of heterogeneous disorders, atrophy of the hippocampus does not necessarily suggest an association with AD. Therefore, our cross-sectional study provided evidence that the morphological changes observed in AD, which are similar to those observed in MCI, are different from those observed in LLD alone.
